Lead Product(s) : Procaine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : Regen Lab
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit
Details : Procaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Genitourinary Syndrome of Menopause.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 23, 2024
Lead Product(s) : Procaine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : Regen Lab
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
